Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A solid-phase receptor binding assay for 125I-hCG.

M Bortolussi, O Selmin, A Colombatti

    Journal of Immunoassay
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical-grade quality platelet-rich plasma releasate (PRP-R/SRGF) from CaCl2 -activated platelet concentrates promoted expansion of mesenchymal stromal cells.

    Vox sanguinis·2016
    Same author

    Long non-coding RNAs and cancer: a new frontier of translational research?

    Oncogene·2012
    Same author

    MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.

    Oncogene·2011
    Same author

    Distinct delta and jagged genes control sequential segregation of pancreatic cell types from precursor pools in zebrafish.

    Developmental biology·2006
    Same author

    Use of reflexology foot massage to reduce anxiety in hospitalized cancer patients in chemotherapy treatment: methodology and outcomes.

    Journal of nursing management·2006
    Same author

    Effects of trichloroethylene and its metabolite trichloroacetic acid on the expression of vimentin in the rat H9c2 cell line.

    Cell biology and toxicology·2005

    A new solid-phase assay simplifies measuring 125I-hCG binding to cell receptors. This faster method efficiently screens for antibodies that block human chorionic gonadotropin binding.

    Area of Science:

    • Biochemistry
    • Immunology
    • Assay Development

    Background:

    • Radioligand-receptor assays (RRAs) are crucial for studying hormone-receptor interactions.
    • Traditional RRAs involving cell membranes in suspension can be time-consuming and complex, requiring centrifugation or filtration.

    Purpose of the Study:

    • To develop a simplified and efficient solid-phase radioligand-receptor assay (RRA) for measuring 125I-labelled human chorionic gonadotropin (125I-hCG) binding.
    • To adapt the assay for high-throughput screening of monoclonal antibodies targeting hCG receptors.

    Main Methods:

    • Development of a solid-phase RRA utilizing microtitration plates with immobilized target cell membranes.
    • Characterization of 125I-hCG binding kinetics, including time, temperature, affinity, and specificity.

    Related Experiment Videos

  • Comparison of the solid-phase RRA with traditional suspension-based RRAs.

    • Main Results:

    • Optimal binding of 125I-hCG to immobilized membranes occurred within 3 hours at 37°C.
    • The binding demonstrated saturation, high affinity (Ka = 2.4 X 10^9 M^-1), and specific inhibition by unlabeled hCG.
    • The solid-phase RRA significantly reduced assay time and complexity by eliminating centrifugation/filtration steps.

    Conclusions:

    • The developed solid-phase RRA offers a simpler, faster, and more efficient alternative to conventional RRAs for measuring 125I-hCG binding.
    • This assay is highly suitable for large-scale sample processing and effective screening of anti-hCG monoclonal antibodies with inhibitory activity.